Lymphoma expert elected ASCO president for 2015-2016 term

Julie M. Vose, MD, MBA, FASCO, an internationally recognized expert in the treatment of lymphoma, has been elected president of ASCO for a 1-year term beginning in June 2015.

Vose will take office as president-elect during the 2014 ASCO Annual Meeting in Chicago.

“ASCO is a very diverse and multifaceted organization with so much to offer its membership. The recent enhancements in the educational offerings, quality improvement, broadened advocacy, and the potential for comparative effectiveness research with CancerLinQ are just a few of the ASCO areas where I believe my experience and training will add to the current activities,” Vose said in a press release. “I am excited to serve the ASCO membership as president and to make a difference for oncology professionals and our patients.”

Vose is the Neumann M. and Mildred E. Harris professorial chair and chief of the oncology/hematology division in the department of internal medicine at the University of Nebraska Medical Center. She also is associate director of clinical research and co-chair of the lymphoma program at the Fred and Pamela Buffet Cancer Center.

Since joining ASCO in 1991, she has served on the board of directors. She is chair of the Cancer Education Committee and is the current chair-elect of the Integrated Media and Technology Committee.

In addition, Vose is a member of the board of directors for the University of Nebraska Medical Center Physicians Group, as well as a co-chair of NCI’s lymphoma steering committee. She also serves on the FDA’s Oncologic Drugs Advisory Committee.